Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Common Equity (2018 - 2025)

Health Catalyst (HCAT) has disclosed Common Equity for 8 consecutive years, with $331.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 6.51% year-over-year to $331.9 million, compared with a TTM value of $331.9 million through Sep 2025, down 6.51%, and an annual FY2024 reading of $365.2 million, changed 0.47% over the prior year.
  • Common Equity was $331.9 million for Q3 2025 at Health Catalyst, down from $347.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $549.2 million in Q3 2021 and bottomed at $268.8 million in Q1 2021.
  • Average Common Equity over 5 years is $392.9 million, with a median of $376.8 million recorded in 2025.
  • The sharpest move saw Common Equity skyrocketed 89.1% in 2021, then decreased 19.89% in 2022.
  • Year by year, Common Equity stood at $522.1 million in 2021, then fell by 18.6% to $425.0 million in 2022, then decreased by 13.67% to $366.9 million in 2023, then dropped by 0.47% to $365.2 million in 2024, then decreased by 9.11% to $331.9 million in 2025.
  • Business Quant data shows Common Equity for HCAT at $331.9 million in Q3 2025, $347.5 million in Q2 2025, and $376.8 million in Q1 2025.